Q2 2025 13F Holders as of 30 Jun 2025
-
Type / Class
-
Equity / Common Stock, $0.0001 par value per share
-
Shares outstanding
-
126,882,307
-
Number of holders
-
67
-
Total 13F shares, excl. options
-
59,755,012
-
Shares change
-
-3,010,306
-
Total reported value, excl. options
-
$43,314,600
-
Value change
-
-$2,449,905
-
Put/Call ratio
-
0%
-
Number of buys
-
35
-
Number of sells
-
44
-
Price
-
$0.7249
Institutional Holders of Nautilus Biotechnology, Inc. - Common Stock, $0.0001 par value per share (NAUT) as of Q2 2025
97 filings reported holding NAUT - Nautilus Biotechnology, Inc. - Common Stock, $0.0001 par value per share as of 30 Jun 2025.
Nautilus Biotechnology, Inc. - Common Stock, $0.0001 par value per share (NAUT) had 67 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 59,755,012 shares of stock of the company.
Largest 10 holders included AH CAPITAL MANAGEMENT, L.L.C., PERCEPTIVE ADVISORS LLC, Cercano Management LLC, Madrona Venture Group, LLC, VANGUARD GROUP INC, Comprehensive Financial Management LLC, AMAZON COM INC, Clarius Group, LLC, MILLENNIUM MANAGEMENT LLC, and Tikvah Management LLC.
This table shows the top 67 institutional shareholders of the security as of 30 Jun 2025.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.